Status:
COMPLETED
Comprehensive Functional Assessments for NOCAD
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Coronary Artery Disease
Myocardial Ischemia
Eligibility:
All Genders
18-80 years
Brief Summary
To validate and investigate the efficacy of comprehensive functional assessments for the diagnostic and prognostic value in NOCAD.
Eligibility Criteria
Inclusion
- visual evaluation of epicardial coronary artery diameter stenosis (DS%) ≤ 50%;
- CZT-SPECT was successfully conducted within three days of CAG
Exclusion
- had flow-limiting epicardial stenosis (DS% \>50%) or angiography-derived FFR (Angio-FFR) ≤ 0.8;
- severe valvular heart disease;
- chronic heart failure and/or left ventricular ejection fraction (LVEF) of \< 50%;
- cardiomyopathy and myocarditis;
- severe renal or hepatic insufficiency;
- failure in detecting SPECT;
- failure in computing Angio-IMR, and -FFR.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06175572
Start Date
January 1 2018
End Date
December 31 2022
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan hospital, Fudan university
Shanghai, China